CHUGAI PHARMACEUTICAL CO., LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,924 JPY | -0.04% |
|
-3.34% | -7.82% |
| May. 01 | Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation | MT |
| Apr. 25 | Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5% | MT |
Presenter SpeechTakaki Koga (Executives)I am Takaki Koga, Polivy Lifecycle Leader at Chugai Ph...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,926
JPY
Average target price
6,093
JPY
Spread / Average Target
+23.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.82% | 52.09B | |
| +32.95% | 698B | |
| +26.51% | 568B | |
| -4.97% | 358B | |
| +18.83% | 328B | |
| +3.54% | 283B | |
| +15.70% | 238B | |
| +6.68% | 203B | |
| -9.08% | 198B | |
| +6.70% | 165B |
- Stock Market
- Equities
- 4519 Stock
- News Chugai Pharmaceutical Co., Ltd
- Transcript : Chugai Pharmaceutical Co., Ltd. - Special Call